Position in NVS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$380,359
-$20,151 QoQ
Shares Held
2,427
-7.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,012
of 1,603 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORDEN GROUP LLC holds $53,447,474 across 12 Drug Manufacturers - General names. NVS ranks #11 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
223,889 | $12,900,484 | |
| 2 | LLY |
ELI LILLY & Co
|
7,327 | $8,788,224 | |
| 3 | JNJ |
Johnson & Johnson
|
34,402 | $8,737,075 | |
| 4 | MRK |
Merck & Co., Inc.
|
45,186 | $5,806,401 | |
| 5 | ABBV |
AbbVie Inc.
|
19,879 | $5,002,351 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
31,176 | $3,938,775 | |
| 7 | AMGN |
Amgen Inc
|
10,471 | $3,791,758 | |
| 8 | NVO |
Novo Nordisk A S
|
38,789 | $1,859,544 |
All Filings in NVS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $380,359 | 2,427 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $400,510 | 2,622 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $296,144 | 2,148 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $262,250 | 2,045 | Shares | Sole | 2025-10-15 | |
| 2025-03-31 | $4,704,344 | 42,199 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $4,092,858 | 42,060 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||